Genmab A/S (CPH:GMAB)
Denmark · Delayed Price · Currency is DKK 3,912.00
+124.00 (3.27%)
Oct 30, 2026, 5:00 PM CET
Genmab Market Cap
Genmab has a market cap or net worth of 233.76 billion as of October 30, 2026. It is the 709th most valuable company in the world and the 5th biggest in Denmark. Its market cap has increased by 104.28% in one year.
Market Cap
233.76B
Enterprise Value
258.38B
Revenue
27.03B
Global Rank
Country Rank
#5 Denmark
PE Ratio
47.26
ChartMarket Cap Chart
Since October 18, 2000, Genmab's market cap has increased from 3.68B to 233.76B, an increase of 6,244.88%. That is a compound annual growth rate of 17.27%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 233.76B | 87.21% |
| Dec 30, 2025 | 124.86B | 31.70% |
| Dec 30, 2024 | 94.81B | -32.65% |
| Dec 29, 2023 | 140.77B | -26.77% |
| Dec 30, 2022 | 192.23B | 11.72% |
| Dec 30, 2021 | 172.06B | 6.80% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.13T |
| Coloplast | 107.74B |
| Demant | 76.51B |
| ALK-Abelló | 54.05B |
| H. Lundbeck | 51.59B |
| Ambu A/S | 20.88B |
| Bavarian Nordic | 19.35B |
| GN Store Nord | 16.42B |